Related Experiment Video
Updated: Dec 21, 2025

10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
14.6K
Expression levels of candidate circulating microRNAs in pediatric tuberculosis
Kathirvel M1, Saranya S2, Mahadevan S1
1Department of Paediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) , Puducherry, India.
Pathogens and Global Health
|May 14, 2020
Summary
Specific microRNAs (miRNAs) in blood show promise as biomarkers for diagnosing pediatric tuberculosis (TB). Upregulated miR-31, miR-155, and downregulated miR-146a effectively identified active TB in children.
Area of Science:
- Biochemistry
- Immunology
- Pediatrics
Background:
- Tuberculosis (TB) remains a significant global health challenge, causing substantial mortality and morbidity.
- MicroRNAs (miRNAs) are crucial regulators of the host immune response, particularly in infectious diseases like TB.
Purpose of the Study:
- To identify circulating miRNAs as potential blood biomarkers for diagnosing active tuberculosis in children.
- To investigate the diagnostic accuracy of specific miRNAs in pediatric TB cases.
Main Methods:
- A cross-sectional study involving 30 children with active TB and 30 healthy controls.
- Quantitative real-time PCR (qRT-PCR) was used to analyze plasma miRNA expression levels.
- Receiver Operating Characteristic (ROC) curve analysis was employed to assess diagnostic performance.
Main Results:
- Significant differences in circulating miRNA expression were observed between active TB cases and healthy controls.
- Upregulation of miR-21, miR-29a, miR-31, and miR-155, and downregulation of miR-146a were noted in children with active TB.
- ROC analysis demonstrated excellent diagnostic potential for miR-31 (AUC 0.978), miR-155 (AUC 0.953), and miR-146a (AUC 0.903).
Conclusions:
- Altered circulating miRNA profiles are associated with immune response dysregulation in pediatric TB.
- miR-31, miR-155, and miR-146a show significant potential as reliable diagnostic biomarkers for active TB in children.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
424
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
424
Pulmonary Tuberculosis I
744
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
744
Pulmonary Tuberculosis V
467
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
467
Pulmonary Tuberculosis II
1.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Pulmonary Tuberculosis III
798
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
798

